Literature DB >> 20711637

Fabrication and evaluation of chitosan-gelatin based buckling implant for retinal detachment surgery.

Hui Chen1, Zhi Zhao, Yahong Zhao, Yumin Yang.   

Abstract

The traditional nonabsorbable silicone buckling implant (buckle) may cause some long-term complications when it is used in the retinal detachment surgery. In this study we fabricated a chitosan-gelatin based buckling implant to replace the traditional one. We evaluated its biocompatibility with human scleral fibroblasts (HSF) in vitro and its cytotoxicity with L929 cell. To evaluate elasticity and hardness of the blends buckle, the mechanical properties of the chitosan-gelatin buckle were compared with the traditional silicone buckle. The light and electron microscopy coupled with immunocytochemistry demonstrated that chitosan-gelatin blends supported the survival and growth of primarily cultured HSF without significant cytotoxic effects. MTT analysis and cell cycle analysis indicated that chitosan-gelatin blends promoted the proliferation of HSF. A preliminary in vivo implantation test indicated that chitosan-gelatin buckling implant were compatible with the surrounding tissue. The results collectively demonstrated that chitosan-gelatin blends could be a candidate biodegradable material for scleral buckling surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711637     DOI: 10.1007/s10856-010-4141-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  28 in total

1.  Study on physical properties and nerve cell affinity of composite films from chitosan and gelatin solutions.

Authors:  Mingyu Cheng; Jinguang Deng; Fei Yang; Yandao Gong; Nanming Zhao; Xiufang Zhang
Journal:  Biomaterials       Date:  2003-08       Impact factor: 12.479

2.  Study of novel chitosan-gelatin artificial skin in vitro.

Authors:  Jinshu Mao; Liguo Zhao; Kang De Yao; Qingxin Shang; Guanghui Yang; Yilin Cao
Journal:  J Biomed Mater Res A       Date:  2003-02-01       Impact factor: 4.396

Review 3.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery.

Authors:  Sunil A Agnihotri; Nadagouda N Mallikarjuna; Tejraj M Aminabhavi
Journal:  J Control Release       Date:  2004-11-05       Impact factor: 9.776

Review 4.  Chitin biotechnology applications.

Authors:  S Hirano
Journal:  Biotechnol Annu Rev       Date:  1996

Review 5.  The sclera and myopia.

Authors:  Jody A Summers Rada; Setareh Shelton; Thomas T Norton
Journal:  Exp Eye Res       Date:  2005-10-03       Impact factor: 3.467

6.  Cross-linking and characterisation of gelatin matrices for biomedical applications.

Authors:  A J Kuijpers; G H Engbers; J Krijgsveld; S A Zaat; J Dankert; J Feijen
Journal:  J Biomater Sci Polym Ed       Date:  2000       Impact factor: 3.517

7.  Repairing of rabbit skull defect by dehydrothermally crosslinked collagen sponges incorporating transforming growth factor beta1.

Authors:  Hiroki Ueda; Tatsuo Nakamura; Masaya Yamamoto; Natsuki Nagata; Seijun Fukuda; Yasuhiko Tabata; Yasuhiko Shimizu
Journal:  J Control Release       Date:  2003-02-14       Impact factor: 9.776

8.  Refractive changes associated with scleral buckling and division in retinopathy of prematurity.

Authors:  D R Chow; P J Ferrone; M T Trese
Journal:  Arch Ophthalmol       Date:  1998-11

9.  Refractive changes following scleral buckling surgery in juvenile retinal detachment.

Authors:  Tomoki Sato; Tsutomu Kawasaki; Michiko Okuyama; Hidenao Ideta
Journal:  Retina       Date:  2003-10       Impact factor: 4.256

10.  Nerve regeneration in a collagen-chitosan tissue-engineered skin transplanted on nude mice.

Authors:  Marie Gingras; Isabelle Paradis; François Berthod
Journal:  Biomaterials       Date:  2003-04       Impact factor: 12.479

View more
  1 in total

Review 1.  The Use of Polymer Blends in the Treatment of Ocular Diseases.

Authors:  Raquel Gregorio Arribada; Francine Behar-Cohen; Andre Luis Branco de Barros; Armando Silva-Cunha
Journal:  Pharmaceutics       Date:  2022-07-07       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.